Venus Remedies Limited (BOM:526953)

Venus Remedies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	1,217	1,028	453.15	284.91	265.66	407.24
Depreciation & Amortization	215.27	175.67	225.06	264.43	322.98	335.34
Other Amortization	81.04	81.04	-	-	-	-
Loss (Gain) From Sale of Assets	5.59	6.19	10.84	-0.56	4.83	0.97
Loss (Gain) From Sale of Investments	-61.77	-59.37	-16.28	-5.51	-0.08	-
Provision & Write-off of Bad Debts	-	-	-	0.61	-	-
Other Operating Activities	234.22	293.82	116.72	104.91	19.23	-116.15
Change in Income Taxes	-342.68	-342.68	-149.22	-154.83	-	-
Change in Other Net Operating Assets	-339.24	375.16	224.16	-121.09	-246.34	-216.38
Operating Cash Flow	1,009	1,558	864.42	372.85	366.27	411.02
Operating Cash Flow Growth	-28.90%	80.20%	131.84%	1.80%	-10.89%	-68.82%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-506.26	-376.56	-96.27	-93.18	-78.18	-137.08
Sale of Property, Plant & Equipment	4.61	1.91	2	4.83	0.74	4.17
Sale (Purchase) of Intangibles	-	-	-84.52	-42	-	-
Investment in Securities	-382.53	-1,466	-633.19	12.71	-199.92	-46.03
Other Investing Activities	17.39	25.19	49.51	45.55	-230.94	11.67
Investing Cash Flow	-866.79	-1,816	-762.48	-72.09	-508.3	-167.27

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Repaid	-	-16.93	-9.54	-	-	-
Long-Term Debt Repaid	-	-8.38	-	-9.89	-4.5	-90.16
Lease Payments	-12.98	-8.38	-	-	-	-
Total Debt Repaid	-26.3	-25.3	-9.54	-9.89	-4.5	-90.16
Net Debt Issued (Repaid)	-26.3	-25.3	-9.54	-9.89	-4.5	-90.16
Other Financing Activities	-10.95	-5.85	-0.65	-0.94	-1.18	-4.62
Financing Cash Flow	-170.85	-31.15	-10.19	-10.83	-5.68	-94.77

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	-10.25	-34.95	-6.08	-12.5	-72.74	-5.21
Miscellaneous Cash Flow Adjustments	0.1	-	-	-0	-	-
Net Cash Flow	-38.57	-324.07	85.68	277.44	-220.44	143.76

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	502.96	1,181	768.15	279.67	288.09	273.94
Free Cash Flow Growth	-58.93%	53.77%	174.66%	-2.92%	5.17%	-77.93%
Free Cash Flow Margin	6.01%	15.35%	11.77%	4.65%	5.19%	4.56%
Free Cash Flow Per Share	37.63	88.36	57.47	20.92	21.55	20.76
Levered Free Cash Flow	178.6	1,051	622.03	67.63	164.48	37.73
Unlevered Free Cash Flow	178.71	1,051	622.44	68.21	165.22	39.62
Free Cash Flow After Leases	489.99	1,173	768.15	279.67	288.09	273.94

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	10.85	5.85	0.65	0.94	1.18	1.78
Cash Income Tax Paid	470.68	342.68	149.22	154.83	-212.12	-
Change in Working Capital	-681.92	32.48	74.94	-275.92	-246.34	-216.38

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error